• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Goldman initiated coverage on Vor Biopharma with a new price target

    4/27/22 6:14:19 AM ET
    $VOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $VOR alert in real time by email
    Goldman initiated coverage of Vor Biopharma with a rating of Neutral and set a new price target of $6.00
    Get the next $VOR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VOR

    DatePrice TargetRatingAnalyst
    7/26/2022$18.00Outperform
    Wedbush
    4/27/2022$6.00Neutral
    Goldman
    12/17/2021$26.00Buy
    HC Wainwright & Co.
    12/3/2021$38.00Outperform
    Robert W. Baird
    12/3/2021$38.00Outperform
    Baird
    12/2/2021$30.00Outperform
    Oppenheimer
    10/19/2021$40.00Market Outperform
    JMP Securities
    More analyst ratings

    $VOR
    SEC Filings

    See more
    • SEC Form 8-K filed by Vor Biopharma Inc.

      8-K - Vor Biopharma Inc. (0001817229) (Filer)

      5/23/25 4:05:25 PM ET
      $VOR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 8-K filed by Vor Biopharma Inc.

      8-K - Vor Biopharma Inc. (0001817229) (Filer)

      5/20/25 4:05:19 PM ET
      $VOR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 10-Q filed by Vor Biopharma Inc.

      10-Q - Vor Biopharma Inc. (0001817229) (Filer)

      5/14/25 4:02:14 PM ET
      $VOR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $VOR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Ra Capital Management, L.P.

      4 - Vor Biopharma Inc. (0001817229) (Issuer)

      5/23/25 5:47:06 PM ET
      $VOR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Director Resnick Joshua

      4 - Vor Biopharma Inc. (0001817229) (Issuer)

      5/23/25 5:45:40 PM ET
      $VOR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Director Lundberg Sven Ante

      4 - Vor Biopharma Inc. (0001817229) (Issuer)

      5/23/25 5:45:14 PM ET
      $VOR
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care